Compounds > ici 204,219
Page last updated: 2024-11-05

ici 204,219 and Sinusitis

ici 204,219 has been researched along with Sinusitis in 3 studies

zafirlukast: a leukotriene D4 receptor antagonist

Sinusitis: Inflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeMarcantonio, MA1
Han, JK1
Lane, SJ1
Ulualp, SO1
Sterman, BM1
Toohill, RJ1

Reviews

2 reviews available for ici 204,219 and Sinusitis

ArticleYear
Systemic therapies in managing sinonasal inflammation.
    Otolaryngologic clinics of North America, 2010, Volume: 43, Issue:3

    Topics: Anti-Inflammatory Agents; Combined Modality Therapy; Drug Therapy; Eosinophils; Histamine Antagonist

2010
Leukotriene antagonism in asthma and rhinitis.
    Respiratory medicine, 1998, Volume: 92, Issue:6

    Topics: Acetates; Asthma; Bronchi; Cyclopropanes; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Leu

1998

Other Studies

1 other study available for ici 204,219 and Sinusitis

ArticleYear
Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease.
    Ear, nose, & throat journal, 1999, Volume: 78, Issue:8

    Topics: Adult; Aged; Aspirin; Asthma; Drug Hypersensitivity; Female; Follow-Up Studies; Humans; Indoles; Leu

1999